🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

99 results for “Lakefront Biotherapeutics NV” Clear

  1. GLPG2451 dose regimen A

    Lakefront Biotherapeutics NV

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  2. GLPG2451 multiple dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  3. GLPG2451 single dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  4. GLPG2737 single dose

    Lakefront Biotherapeutics NV

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  5. GLPG2737 single dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  6. GLPG3067 single dose

    Lakefront Biotherapeutics NV

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  7. GLPG3067 single dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  8. GLPG3121

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  9. GLPG3121 SAD

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  10. GLPG3312 IR

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  11. GLPG3667

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    3 trials

  12. GLPG3667

    Lakefront Biotherapeutics NV

    Plaque Psoriasis

    phase 1 small molecule completed

    1 trial

  13. GLPG3667 capsule

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  14. GLPG3667 oral suspension

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  15. GLPG3970 film-coated tablet

    Lakefront Biotherapeutics NV

    Systemic Lupus Erythematosus

    phase 1 small molecule terminated

    1 trial

  16. GLPG3970 film-coated tablet

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  17. GLPG3970 oral solution

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  18. GLPG4059 oral suspension

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule terminated

    1 trial

  19. GLPG4399 oral suspension

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  20. GLPG4716

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  21. MOR106

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule terminated

    1 trial

  22. MOR106 single ascending doses, intravenous

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  23. Pirfenidone

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  24. Sulfasalazine

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources